Peter Goadsby, Professor of Neurology at King's College London’s Institute of Psychiatry, Psychology & Neuroscience (IoPPN), and Director at the National Institute for Health Research-Wellcome Trust Clinical Research Facility (NIHR CRF), King's College Hospital has been awarded the world’s top Brain Prize from the Lundbeck Foundation for his pioneering migraine research.
By
NIHR Maudsley BRC at 4 Mar 2021
King’s College London study assesses the potential impacts of COVID-19 nationwide lockdown on longer term depression, anxiety, and stress in gamblers in the UK.
By
NIHR Maudsley BRC at 25 Jan 2021
A new BRC supported study by King’s College London has shown an association between increases in alcohol related hospital admissions and decreases in spending on alcohol services since they came under the responsibility of local authorities in 2012.
By
NIHR Maudsley BRC at 2 Jul 2020
A single case study of an individual with longstanding heroin addiction has shown heroin-induced slow and ineffective breathing, as well as apnoea, in research from the NIHR Maudsley BRC.
By
NIHR Maudsley BRC at 26 Mar 2020
Fremanezumab, a new drug preventing chronic migraine, has been recommended in final draft guidance from National Institute for health and Care Excellence (NICE) today (12 March 2020) following clinical trials based on research led by King’s College London.
By
NIHR Maudsley BRC at 12 Mar 2020